Share statistics (as at 30 June 2020)

Number of Ordinary Shares in issue (undiluted) 245,626,926
Number of Ordinary Shares subject to options 6,405,000
Maximum number of Ordinary Shares in issue (fully diluted) 252,034,926

The effect of the options, if all were exercised, would be to increase the issued share capital by 2.61% and raise £2,147,400 for the Company.

There are no restrictions on the transfer of Futura Medical plc shares.

Major shareholders (as at 30 June 2020)

Shareholders holding more than 3% of the share capital of Futura were:

Lombard Odier Asset Management (Europe) Limited 21.04%
T Adams 8.08%
WT Lamb Investments Limited 5.23%
RA Lamb 3.71%

Shares not in public hands (as at 30 June 2020)

In terms of the AIM Rules and insofar as it is aware, 21.99% of the Company's AIM securities are not in public hands.

Shares held in treasury (as at 30 June 2020)

In terms of the AIM Rules, there are no shares held in treasury.

Share volumes (as at 30 June 2020)

The daily average number of shares traded since 2014 is:

 

Daily Average Per Year Since 2014 ('000)
2019 1,484
2018 459
2017 309
2016 295
2015 155
2014 154
/tr>
Daily Average Per Month in 2020 ('000)
January 1,229
February 1,326
March 918
April 914
May 2100
June 779

Share options (as at 30 June 2020)

The number of ordinary shares subject to options granted under the Share Option Schemes of the Company were:

Grant Exercise period (incl) Exercise
price/share
No of share options granted Cash to Company on exercise
09/13 10/15 - 09/20 71.50p 620,000 £443,300
09/14 10/16 - 09/21 51.75p 480,000 £248,400
09/15 10/17 - 09/22 30.00p 600,000 £180,000
01/17 10/18 - 09/23 57.50p 810,000 £465,750
09/17 10/19 - 09/24 30.50p 990,000 £301,950
11/18 10/20 - 09/25 7.50p 1,240,000 £93,000
01/19 01/20 - 12/24 7.20p 212,500 £15,300
01/19 09/20 - 10/25 7.20p 212,500 £15,300
09/19 10/21 - 09/26 31.00p 1,240,000 £384,400
Totals 6,405,000 £2,147,400

Further details of share options issued can be obtained from the Company's Annual Report 2019 which can be found in the Corporate Documentation.